Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Canada
/
Pharmaceuticals & Biotech
/
Green Thumb Industries
GTII
Green Thumb Industries
Federal Legalization And Wellness Trends Will Transform Cannabis Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
10 Jul 25
Updated
15 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
CA$21.06
49.4% undervalued
intrinsic discount
15 Aug
CA$10.66
Loading
1Y
-30.4%
7D
8.4%
Author's Valuation
CA$21.1
49.4% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
CA$21.1
49.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-46m
1b
2016
2018
2020
2022
2024
2025
2026
2028
Revenue US$1.3b
Earnings US$151.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.74%
Pharma revenue growth rate
1.05%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.30%
Calculation
US$151.23m
Earnings '28
x
26.52x
PE Ratio '28
=
US$4.01b
Market Cap '28
US$4.01b
Market Cap '28
/
219.43m
No. shares '28
=
US$18.28
Share Price '28
US$18.28
Share Price '28
Discounted to 2025 @ 6.30% p.a.
=
US$15.22
Fair Value '25
US$15.22
Fair Value '25
Converted to CAD @ 1.3813 USD/CAD Exchange Rate
=
CA$21.02
Fair Value '25